鶹-Site Updates /index.html English News Release,Information,Latest News. Application Submitted for LENVIMA® (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG® (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy /news/2026/news202621.html 鶹's news release Application Submitted for LENVIMA® (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG® (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy is posted. 2026-03-27T10:00:00+09:00 鶹 and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency /news/2026/news202620.html 鶹's news release 鶹 and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency is posted. 2026-03-27T08:00:00+09:00 Notice of Nominees for Directors /news/2026/news202618.html 鶹's news release Notice of Nominees for Directors is posted. 2026-03-26T17:00:00+09:00 Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026 /news/2026/news202616.html 鶹's news release Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026 is posted. 2026-03-23T08:30:00+09:00 Regarding Discontinuation of Administration of “Tazverik® Tablets 200mg” (tazemetostat hydrobromide) /news/2026/news202615.html 鶹's news release Regarding Discontinuation of Administration of “Tazverik® Tablets 200mg” (tazemetostat hydrobromide) is posted. 2026-03-19T07:30:00+09:00 鶹 Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation /news/2026/news202614.html 鶹's news release 鶹 Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation is posted. 2026-03-17T16:45:00+09:00 Have Fun Exploring Sleep with Pokémon! 鶹 Launches Awareness Campaign on Importance of Sleep Through "Pokémon Sleep" Collaboration /news/2026/news202613.html 鶹's news release Have Fun Exploring Sleep with Pokémon! 鶹 Launches Awareness Campaign on Importance of Sleep Through "Pokémon Sleep" Collaboration is posted. 2026-03-12T12:00:00+09:00 鶹 to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting /news/2026/news202612.html 鶹's news release 鶹 to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting is posted. 2026-03-11T08:30:00+09:00 WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) /news/2026/news202611.html 鶹's news release WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) is posted. 2026-03-02T08:30:00+09:00 鶹’s Kawashima Plant Honored with “Gifu Decarbonization Top Runner Award” - Recognized for Proactive Initiatives to Reduce Greenhouse Gas Emissions - /information/2026/pdf/e20260226.pdf 鶹's information 鶹’s Kawashima Plant Honored with “Gifu Decarbonization Top Runner Award” - Recognized for Proactive Initiatives to Reduce Greenhouse Gas Emissions - is posted. 2026-02-26T15:00:00+09:00 鶹 Selected for “Thought Leaders of Human Capital 2025” and “Human Capital Management Excellence 2025 Gold Award” for Third Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives /information/2026/pdf/e20260220.pdf 鶹's information 鶹 Selected for “Thought Leaders of Human Capital 2025” and “Human Capital Management Excellence 2025 Gold Award” for Third Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives is posted. 2026-02-20T11:35:39+09:00 Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy /news/2026/news202610.html 鶹's news release Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy is posted. 2026-02-16T14:30:00+09:00 Sustainability “World Neglected Tropical Disease (NTD) Day (January 30) Internal Awareness Event” /sustainability/atm/ntds/activity/068.html 鶹's latest news Sustainability “World Neglected Tropical Disease (NTD) Day (January 30) Internal Awareness Event” is posted. 2026-02-10T21:10:00+09:00 IR “Third Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2026 (Material, Webcast)” /ir/library/presentations/index.html 鶹's latest news IR “Third Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2026 (Material, Webcast)” is posted. 2026-02-09T15:30:00+09:00 鶹 Announces Appointment of Corporate Officers /news/2026/news202609.html 鶹's news release 鶹 Announces Appointment of Corporate Officers is posted. 2026-02-09T15:30:00+09:00